https://www.prnewswire.com/news-releases/alkermes-to-host-conference-call-to-discuss-third-quarter-2018-financial-results-300732009.html
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:30 a.m. ET (1:30 p.m. BST) on Tuesday, Oct. 23, 2018,...
conference callthird quarteralkermeshostdiscuss
https://endpoints.news/dispatches-from-jefferies-why-alkermes-wants-avadel-light-chains-hope-for-cd47-and-more/
Nov 21, 2025 - Jefferies Healthcare Conference in London sees strong attendance. GSK announces LTZ deal, Alkermes ups Avadel bid, Light Chain defends CD47 approach, Vesper...
dispatchesjefferiesalkermeswantslight
https://panciapiena-it.com/ricetta/ciaramicola/
Dolce umbro soffice e colorato con Alkermes e meringa. Scopri la ricetta tradizionale della Ciaramicola per la tua Pasqua!
dolcepasqualeumbroconmeringa
https://www.nasdaq.com/market-activity/stocks/alks/dividend-history
Stay up-to-date on Alkermes plc Ordinary Shares (ALKS) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.
alkermes plcordinary sharesalksdividendhistory
https://www.alkermes.com/privacy
We urge all users of our website to read this Privacy Policy to learn more about the policies and practices that we developed to safeguard personal information.
online privacypolicyalkermes
https://www.biospace.com/alkermes-advances-alks-4230-into-monotherapy-expansion-phase-of-artistry-1-in-patients-with-renal-cell-carcinoma-or-melanoma
Alkermes plc announced the initiation of the monotherapy expansion stage of its ARTISTRY-1 clinical trial to evaluate the efficacy, safety and tolerability of...
alkermesadvancesalksmonotherapyexpansion